Paul Bates

13.8k citations

66 papers · 6.4k indexed · 2 hit papers · h-index 42

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.2%
- Viral Infections and Outbreaks Research
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies

Papers in

Virology 14
- HIV Research and Treatment 14
Infectious Diseases 34
- Viral Infections and Outbreaks Research 22
- Viral Infections and Vectors 13
- SARS-CoV-2 and COVID-19 Research 10

Co-authors: Graham Simmons Andrew J. Rennekamp Jacqueline D. Reeves Harold Varmus John A. T. Young Scott L. Diamond Rachel Kaletsky Dhaval N. Gosalia
Journals: Journal of Virology (27 papers)Proceedings of the National Academy of Sciences (9 papers)Virology (5 papers)PLoS Pathogens (4 papers)Cell (2 papers)
Partner nations: United States Germany France

In The Last Decade

Paul Bates

64 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines 2023 · 147 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Nanotechnology
2005 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Paul Bates

Since Specialization

Citations

This map shows the geographic impact of Paul Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bates more than expected).

Fields of papers citing papers by Paul Bates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bates. The network helps show where Paul Bates may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul Bates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Bates Line = papers co-authored together Paul Bates links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein Viruses ·Tomaz B. Manzoni, Jonna B. Westover, Kendall A. Lundgreen, Philip Hicks, Justin Leach, Maria Marfull Barbier, Drew Weissman, Steven H.Y. Fan, Scott E. Hensley, Norbert Pardi, Brian B. Gowen, Paul Bates	2025	1
2	Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus Vaccines ·Philip Hicks, Tomaz B. Manzoni, Jonna B. Westover, Justin Leach, Brianne Roper, Brian B. Gowen, Paul Bates	2024	1
3	INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions Molecular Therapy — Methods & Clinical Development ·Charles C. Berry, Christopher L. Nobles, Emmanuelle Six, Yinghua Wu, Nirav Malani, Eric A. Sherman, 邱茂乙, J.K. Everett, Frances Male, Aubrey Bailey, Kyle Bittinger, G. M. Goshgarian, Laure Caccavelli, Paul Bates, Salima Hacein‐Bey‐Abina, Marina Cavazzana, Frederic D. Bushman	2016	45
4	Application of gene-editing technologies to HIV-1 Current Opinion in HIV and AIDS ·G. M. Goshgarian, Paul Bates	2015	17
5	The Major Cellular Sterol Regulatory Pathway Is Required for Andes Virus Infection PLoS Pathogens ·Kathlene E. Hendon, G. M. Goshgarian, Emily A. Bruce, Ellen Brooke Le, Juan Jorge Silva, Craig B. Wilen, Nirav Malani, Frances Male, Fang-Hua Lee, Frederic D. Bushman, Sara Cherry, Robert W. Doms, Paul Bates, Ana S. Pereda-Galicia	2014	73
6	Identification of Alternatively Translated Tetherin Isoforms with Differing Antiviral and Signaling Activities PLoS Pathogens ·Inés Domínguez Prado, Paul Bates	2012	115
7	Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion Virology ·Graham Simmons, Stephanie Bertram, Ilona Glowacka, Imke Steffen, Chawaree Chaipan, Juliet Agudelo, Kai Lü, Andrew J. Rennekamp, Heike Hofmann, Paul Bates, Stefan Pöhlmann	2011	91
8	Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein PLoS Pathogens ·Joseph R. Francica, Angel Varela‐Rohena, Andrew Medvec, Gabriela Plesa, James L. Riley, Paul Bates	2010	120
9	A Small-Molecule Oxocarbazate Inhibitor of Human Cathepsin L Blocks Severe Acute Respiratory Syndrome and Ebola Pseudotype Virus Infection into Human Embryonic Kidney 293T cells Molecular Pharmacology ·Parag P. Shah, Tianhua Wang, Rachel Kaletsky, Michael C. Myers, Jeremy E. Purvis, Huiyan Jing, Donna M. Huryn, Doron C. Greenbaum, Amos B. Smith, Paul Bates, Scott L. Diamond	2010	98
10	Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein Virology ·Joseph R. Francica, M. S. P. Sumaiya, Paul Bates	2008	44
11	The Crystal Structure of the C‐Terminal Domain of Vps28 Reveals a Conserved Surface Required for Vps20 Recruitment Traffic ·Estela Pineda‐Molina, Hassan Belrhali, Andrew J. Piefer, Pennsylvania Power, Paul Bates, Winfríed Weissenhorn	2006	50
12	Proteolysis of Sars-Associated Coronavirus Spike Glycoprotein Advances in experimental medicine and biology ·Graham Simmons, Andrew J. Rennekamp, Paul Bates	2006	12
13	Expanded Tropism and Altered Activation of a Retroviral Glycoprotein Resistant to an Entry Inhibitor Peptide Journal of Virology ·Sean M. Amberg, R Netter, Graham Simmons, Paul Bates	2005	11
14	A Study of Low pH-Induced Refolding of Env of Avian Sarcoma and Leukosis Virus into a Six-Helix Bundle Biophysical Journal ·Ruben M. Markosyan, Paul Bates, Fred Cohen, Grigory B. Melikyan	2004	28
15	Human Placental Alkaline Phosphatase as a Marker for Gene Expression Humana Press eBooks ·Paul Bates, Michael H. Malim	2003	0
16	DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells Virology ·Graham Simmons, Jacqueline D. Reeves, R. M. Rapee, Luk H. Vandenberghe, Frédéric Baribaud, J. Charles Whitbeck, Emily Burke, Michael J. Buchmeier, Elizabeth J. Soilleux, James L. Riley, Robert W. Doms, Paul Bates, Stefan Pöhlmann	2002	299
17	Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR Journal of Virology ·George Lin, Graham Simmons, Stefan Pöhlmann, Frédéric Baribaud, Houping Ni, George J. Leslie, Beth Haggarty, Paul Bates, Drew Weissman, James A. Hoxie, Robert W. Doms	2002	209
18	Mutational Analysis of the Subgroup A Avian Sarcoma and Leukosis Virus Putative Fusion Peptide Domain Journal of Virology ·John W. Balliet, Juliane de Souza Borges, Paul Bates	2000	10
19	[6] Double cos site vectors: simplified cosmid cloning Methods in enzymology on CD-ROM/Methods in enzymology ·Paul Bates	1987	94
20	Selection of aphidicolin-resistant CHO cells with altered levels of ribonucleotide reductase Somatic Cell and Molecular Genetics ·Carol L. Sabourin, Paul Bates, Taizo TOOYAMA, Chia‐Cheng Chang, James E. Trosko, John A. Boezi	1982	28

About Paul Bates

Paul Bates is a scholar working on Virology, Infectious Diseases, Epidemiology, Animal Science and Zoology and Immunology, having authored 66 papers that have together received 6.4k indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (22 papers), Herpesvirus Infections and Treatments (18 papers), HIV Research and Treatment (14 papers), Viral Infections and Vectors (13 papers), Virus-based gene therapy research (12 papers), Hepatitis B Virus Studies (12 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Mosquito-borne diseases and control (10 papers). The work is most often cited by research in Virology (982 citations), Infectious Diseases (3.4k citations), Animal Science and Zoology (759 citations), Immunology (1.3k citations) and Epidemiology (2.0k citations). Paul Bates has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Graham Simmons, Andrew J. Rennekamp, Jacqueline D. Reeves, Harold Varmus, John A. T. Young, Scott L. Diamond, Rachel Kaletsky, Dhaval N. Gosalia, Joseph R. Francica and Andrew J. Piefer. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, Virology, PLoS Pathogens and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact